{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:37:20Z","timestamp":1758703040102},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.7759\/cureus.16804","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T13:16:28Z","timestamp":1627823788000},"source":"Crossref","is-referenced-by-count":1,"title":["Sweet\u2019s Syndrome in a Patient With Seropositive Rheumatoid Arthritis After Starting Adalimumab: Is Sweet\u2019s Syndrome Related to Rheumatoid Arthritis or Is It the Paradoxical Effect of Adalimumab?"],"prefix":"10.7759","author":[{"given":"Prodip","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad P","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishouri","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipon","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"An acute febrile neutrophilic dermatosis","volume":"76","author":"Sweet RD","year":"1964","unstructured":"Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964, 76:349-56. 10.1111\/j.1365-2133.1964.tb14541.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen PR","year":"2007","unstructured":"Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007, 2:34. 10.1186\/1750-1172-2-34","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000088466","article-title":"Sweet's syndrome--an extraintestinal manifestation in inflammatory bowel disease","volume":"72","author":"Ytting H","year":"2005","unstructured":"Ytting H, Vind I, Bang D, Munkholm P. Sweet's syndrome--an extraintestinal manifestation in inflammatory bowel disease. Digestion. 2005, 72:195-200. 10.1159\/000088466","journal-title":"Digestion"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s1578-2190(10)70846-5","article-title":"Sweet syndrome in a pregnant woman (Article in Spanish)","volume":"101","author":"Serrano-Falc\u00f3n C","year":"2010","unstructured":"Serrano-Falc\u00f3n C, Serrano-Falc\u00f3n MM. Sweet syndrome in a pregnant woman (Article in Spanish). Actas Dermosifiliogr. 2010, 101:558-9. 10.1016\/s1578-2190(10)70846-5","journal-title":"Actas Dermosifiliogr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.12.009","article-title":"Characteristics of Sweet Syndrome in patients with acute myeloid leukemia","volume":"15","author":"Kazmi SM","year":"2015","unstructured":"Kazmi SM, Pemmaraju N, Patel KP, et al.. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015, 15:358-63. 10.1016\/j.clml.2014.12.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003033","article-title":"Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant: a comparative series of 62 patients","volume":"95","author":"Ghoufi L","year":"2016","unstructured":"Ghoufi L, Ortonne N, Ingen-Housz-Oro S, et al.. Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant: a comparative series of 62 patients. Medicine (Baltimore). 2016, 95:e3033. 10.1097\/MD.0000000000003033","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.0303-6987.2002.029.x","article-title":"Sweet syndrome in multiple myeloma: a series of six cases","volume":"30","author":"Bayer-Garner IB","year":"2003","unstructured":"Bayer-Garner IB, Cottler-Fox M, Smoller BR. Sweet syndrome in multiple myeloma: a series of six cases. J Cutan Pathol. 2003, 30:261-4. 10.1046\/j.0303-6987.2002.029.x","journal-title":"J Cutan Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000017","article-title":"Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy","volume":"23","author":"Pintova S","year":"2013","unstructured":"Pintova S, Sidhu H, Friedlander PA, Holcombe RF. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res. 2013, 23:498-501. 10.1097\/CMR.0000000000000017","journal-title":"Melanoma Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8351-x","article-title":"Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria","volume":"45","author":"Marzano AV","year":"2013","unstructured":"Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013, 45:202-10. 10.1007\/s12016-012-8351-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00414","article-title":"Insights into the pathogenesis of sweet's syndrome","volume":"10","author":"Heath MS","year":"2019","unstructured":"Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of sweet's syndrome. Front Immunol. 2019, 10:414. 10.3389\/fimmu.2019.00414","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0503","article-title":"Refractory subcutaneous sweet syndrome treated with adalimumab","volume":"152","author":"Agarwal A","year":"2016","unstructured":"Agarwal A, Barrow W, Selim MA, Nicholas MW. Refractory subcutaneous sweet syndrome treated with adalimumab. JAMA Dermatol. 2016, 152:842-4. 10.1001\/jamadermatol.2016.0503","journal-title":"JAMA Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068254","article-title":"Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome","volume":"67","author":"Delluc A","year":"2008","unstructured":"Delluc A, Limal N, Pu\u00e9chal X, Franc\u00e8s C, Piette JC, Cacoub P. Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Ann Rheum Dis. 2008, 67:278-9. 10.1136\/ard.2006.068254","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13352","article-title":"Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study","volume":"42","author":"Pugliese D","year":"2015","unstructured":"Pugliese D, Guidi L, Ferraro PM, et al.. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther. 2015, 42:880-8. 10.1111\/apt.13352","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201210001-01280","article-title":"Sweet's syndrome in Crohn's disease patient after treatment with Humira\u00ae","volume":"107","author":"Alsaleh A","year":"2012","unstructured":"Alsaleh A, Glover S, Alkhasawneh A. Sweet's syndrome in Crohn's disease patient after treatment with Humira\u00ae. Am J Gastroenterol. 2012, 107:S508-9.","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.10.2011.4935","article-title":"Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis","volume":"2011","author":"Keidel S","year":"2011","unstructured":"Keidel S, McColl A, Edmonds S. Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis. BMJ Case Rep. 2011, 2011:bcr1020114935. 10.1136\/bcr.10.2011.4935","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/17402520500134254","article-title":"Crohn's disease associated with Sweet's syndrome and Sj\u00f6gren's syndrome treated with infliximab","volume":"12","author":"Foster EN","year":"2005","unstructured":"Foster EN, Nguyen KK, Sheikh RA, Prindiville TP. Crohn's disease associated with Sweet's syndrome and Sj\u00f6gren's syndrome treated with infliximab. Clin Dev Immunol. 2005, 12:145-9. 10.1080\/17402520500134254","journal-title":"Clin Dev Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1089","article-title":"Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept","volume":"54","author":"Yamauchi PS","year":"2006","unstructured":"Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM. Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006, 54:S122-6. 10.1016\/j.jaad.2005.11.1089","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14461","article-title":"Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: a review","volume":"34","author":"Yang JJ","year":"2021","unstructured":"Yang JJ, Maloney NJ, Nguyen KA, Worswick S, Smogorzewski J, Bach DQ. Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: a review. Dermatol Ther. 2021, 34:e14461. 10.1111\/dth.14461","journal-title":"Dermatol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2016.05.021","article-title":"Sweet syndrome: a review and update","volume":"107","author":"Villarreal-Villarreal CD","year":"2016","unstructured":"Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Mart\u00ednez A. Sweet syndrome: a review and update. Actas Dermosifiliogr. 2016, 107:369-78. 10.1016\/j.adengl.2016.05.021","journal-title":"Actas Dermosifiliogr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60590-sweets-syndrome-in-a-patient-with-seropositive-rheumatoid-arthritis-after-starting-adalimumab-is-sweets-syndrome-related-to-rheumatoid-arthritis-or-is-it-the-paradoxical-effect-of-adalimumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:47Z","timestamp":1707507227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60590-sweets-syndrome-in-a-patient-with-seropositive-rheumatoid-arthritis-after-starting-adalimumab-is-sweets-syndrome-related-to-rheumatoid-arthritis-or-is-it-the-paradoxical-effect-of-adalimumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.16804","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}